Tags : NWS Holdings


Medopad secures £19.43 million Series B investment led by Leaps

Medopad Discloses Funding for Ambitious Digital Medicine Innovations Leaps by Bayer led $25M Series B investment to support clinical studies, technology development, geographic expansion and commercial growth Medopad shares plan to discover and validate digital biomarkers of chronic diseases including Parkinson’s, Alzheimer’s and Diabetes New sciences for life science companies begins with project with pharmaceutical […]Read More